News for Northwest Biotherapeutics, Inc. (NWBO)

Northwest Biotherapeutics Inc. faces a $19.4 million net loss in Q3. The firm, specializing in innovative cancer treatments, reported a revenue of $357,

Northwest Biotherapeutics ratifies executive compensation, re-elects directors

AGOURA HILLS, Calif., Aug. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We" or “Our”), announced...

Surge in cases of various types of cancers, including breast, lung, and liver, globally drives growth of the cancer vaccine market....

LAS VEGAS, March 09, 2023 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC:AABB) (

The global castration-resistant prostate cancer (CRPC) treatment market will grow at a CAGR of more than 9.5% during the forecast period. This market...

On December 14th, the Federal Reserve hiked its key interest rate by 50 basis points. This was the first deceleration in rate hike increases in 2022; between March and November 2022, the interest rate had jumped 25 basis points, 50 basis points and then 75 points four times in a row in between each Federal Reserve meeting.

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 5.56% in November, recording two subsequent monthly increases for the first time in 2022.

In a new lawsuit, Northwest Biotherapeutics accuses market makers of illicit ‘spoofing’ trades

In a new lawsuit, Northwest Biotherapeutics accuses market makers of illicit ‘spoofing’ trades

EQS-News: OTC Markets The OTCQB Venture Market Records 4 Months Of Consecutive Volume Increases In OTC Market Group’s Most-Active List In October 15.11.2022 / 14:15... | November 15, 2022

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) increased by 8.13% in October — its second-largest monthly increase in 2022.

The SPDR S&P 500 ETF Trust (NYSEARCA: SPY) declined by 9.62% in September – its largest decline in 2022.

Reflecting the expected conditions of a bear market, many of the world’s indices saw a decrease in price throughout June.

Reflecting the world’s uncertainty about the U.S. economy, the market’s major indices saw incredible volatility in May.

OTC penny stocks are risky but rewarding. If you’re looking for an alternative investment, they’re great. Check out the OTC penny stocks I've listed below.